Systemic Therapy for Advanced and Metastatic Colon Cancer / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 202-206, 2019.
Artículo
en Coreano
| WPRIM
| ID: wpr-742161
ABSTRACT
Colon cancer is one of the three most common cancers in both men and women in Organization for Economic Cooperation and Development countries. Approximately one-quarter of colon cancer patients have a metastasis at the time of diagnosis, and systemic therapy is used in many of them as a first line therapy. In addition to existing cytotoxic drugs, target therapy has been introduced in colon cancer and immunotherapy has shown clinical benefits in the treatment of metastatic colon cancer. The purpose of this review was to briefly summarize the National Comprehensive Cancer Network guidelines for systemic therapy in colon cancer with special reference to targeted agents and novel agents.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Colon
/
Neoplasias del Colon
/
Diagnóstico
/
Organización para la Cooperación y el Desarrollo Económico
/
Inmunoterapia
/
Metástasis de la Neoplasia
Tipo de estudio:
Estudio diagnóstico
/
Guía de Práctica Clínica
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Coreano
Revista:
The Korean Journal of Gastroenterology
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS